查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439857

碘：市場佔有率分析、產業趨勢與統計、成長預測（2024-2029）

Iodine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)
出版日期: | 出版商: Mordor Intelligence | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計2024年碘市場規模為40.64千噸，預計2029年將達到52.88千噸，在預測期間（2024-2029年）年複合成長率為5.41%。

碘市場

COVID-19 大流行、全球封鎖、製造活動和供應鏈中斷以及生產停頓對市場產生了負面影響。然而，由於醫療產業的需求和 2021 年的復甦情勢，預測期內的市場成長軌跡已經恢復。

主要亮點

  • 短期內，X光顯影劑需求的增加、碘缺乏發生率的增加以及碘衍生物的廣泛應用預計將推動碘需求。
  • 然而，碘毒性和過量攝取導致的健康相關問題是市場研究的主要限制因素。
  • 然而，對除生物劑不斷成長的需求預計將是一個機會。
  • 從應用來看，由於擴大使用碘來治療甲狀腺腫等疾病，醫療領域預計將主導市場。
  • 歐洲主導全球碘市場，德國、英國和法國等國主要消費碘。

碘市場趨勢

醫療領域佔市場主導地位

  • 碘是穩定鹵素中最重的化學元素。在標準狀態下，它是一種閃亮的紫黑色非金屬固體，在溫和的熱量下很容易昇華。
  • 在醫療領域用於X光顯影劑、藥品、碘劑、優碘（消毒劑）等。近年來，由於對 X 光顯影劑、低毒性、高原子序數以及易於與有機化合物結合的需求不斷增加，對碘的需求增加。
  • 此外，帶碘化合物是含有碘和增溶劑的溶液。這會緩慢地將少量碘釋放到溶液中。最廣泛使用的碘劑之一是優碘，通常用於釀酒廠和乳品加工業對錶面進行消毒。
  • 醫療技術的進步正在推動這項應用對碘的需求。含碘的 X 光顯影劑可提高 X 光成像過程中血管結構和器官的可見度。
  • 放射性碘是治療方法甲狀腺癌的有效方法。這是因為飲料和膠囊釋放的放射性碘被吸收到體內並被甲狀腺癌細胞吸收。然後輻射會破壞癌細胞。
  • 歐洲製藥工業和協會聯合會 (EFPIA) 腫瘤學平台支持歐洲的醫療創新，並提供有利的環境，為癌症患者提供新的治療方法。該平台正在開發1,400多種癌症藥物，計劃於2021年啟動1,300多項癌症臨床試驗。
  • 此外，碘在醫藥上用於製備消毒劑、殺菌劑、鎮痛劑等（例如碘酊），以及用於合成碘化鈉、碘化鉀、碘溶液等。
  • 此外，製藥業在北美最大，其次是歐洲和亞太地區。目前，在印度、中國、印尼等亞太國家，學名藥生產在地區藥品生產中佔據主導地位，製藥業的成長正在快速發展。
  • 根據IBEF預測，印度國內醫藥市場預計2021年將達420億美元，2030年將達120-1300億美元。
  • 由於此類舉措、研究和開發以及醫療部門的強勁需求，預計預測期內對碘的需求將增加。

歐洲主導市場

  • 由於德國、英國、英國等國消費量的增加，歐洲已成為碘消費的主要市場。
  • 德國是世界上最大的經濟強國之一。醫療技術的進步和對飼料的巨大需求正在推動該國的碘需求。
  • 根據Altech Agri-Food Outlook 2022，2021年中國飼料產量約2,451萬噸，而2020年為2,493萬噸。
  • 該國的公司包括 AGRAVIS Raiffeisen AG、DTC Deutsche Tiernahrung Cremer GmbH &Co.KG、H. Broring GmbH &Co.KG、MEGA Tierernahrung GMBH &Co.KG 和 Rothkotter-Mischfutterwerk。
  • 然而，2021年，配合飼料生產受到畜禽傳染性疾病禽流感（AI）蔓延的嚴重影響。總體而言，該國飼料產業成長保持平穩，預計 2022 年將實現成長。因此，這樣的趨勢也影響了年內國內的碘需求。
  • 預計在預測期內，老年人口的增加和對治療慢性病的醫療保健設施的需求不斷增加將支持該國製藥業和藥品製造碘消耗的成長。
  • 此外，英國製藥業正在加速投資研發、創新和建立更多國內製造地。
  • 英國醫藥市場位居全球前10位，約佔全球醫藥產業的2.5%。在英國生產的藥品中，41% 用於出口，30% 用於國內市場，其餘 (28%) 是用於生產其他藥品的材料。
  • 英國國家統計局數據顯示，2022年5月基本藥物產量較上季成長3.2%。此外，2021年第四季度，基本藥物和藥物製劑產量較2021年第三季成長12.5%。
  • 截至2021年6月1日，英國綿羊和羔羊數量持續年減2.7%至1463萬頭。然而，生豬（424萬頭）和家禽（14,108萬頭）分別成長5.4%和5%。因此，隨著飼料成分的增加，動物飼料的消費量也預計會增加。
  • 法國國內藥品市場監管嚴格，符合報銷資格的藥品約佔銷售額的30%。學名藥製造商與品牌藥製造商之間存在著激烈的競爭。

碘工業概況

市場趨於整合，前四家公司約佔全球市場的 70%。市場主要企業（排名不分先後）包括 SQM SA、ISE CHEMICALS CORPORATION、Cosayach、Iochem Corporation 和 Algorta Norte。

其他福利：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月的分析師支持

目錄

第1章簡介

  • 調查先決條件
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 促進因素
    • X光顯影劑需求增加
    • 碘缺乏症增加
    • 碘衍生物的廣泛應用
  • 抑制因素
    • 碘毒性和健康問題
    • 其他阻礙因素
  • 產業價值鏈分析
  • 波特五力分析
    • 供應商的議價能力
    • 消費者議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭程度

第5章市場區隔

  • 醬
    • 地下鹵水
    • 卡利甚礦石
    • 回收
    • 海藻
  • 型態
    • 無機鹽和錯合
    • 有機化合物
    • 元素和同位素
  • 目的
    • 動物飼料
    • 醫療用途
    • 除生物劑
    • 光學偏光片
    • 氟化學
    • 尼龍
    • 其他用途（人類營養和催化劑）
  • 地區
    • 亞太地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 其他亞太地區
    • 北美洲
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 法國
      • 英國
      • 義大利
      • 其他歐洲國家
    • 南美洲
      • 巴西
      • 阿根廷
      • 南美洲其他地區
    • 中東/非洲
      • 沙烏地阿拉伯
      • 南非
      • 其他中東和非洲

第6章 競爭形勢

  • 併購、合資、聯盟、協議
  • 市場佔有率分析
  • 主要企業策略
  • 公司簡介
    • ACF Minera SA
    • American Elements
    • Algorta Norte SA
    • Calibre Chemicals Pvt. Ltd
    • Cosayach
    • Deep Water Chemicals
    • Eskay Iodine
    • Glide Chem Private Limited
    • GODO SHIGEN Co. Ltd
    • Infinium Pharmachem Pvt. Ltd
    • Iochem Corporation
    • Iofina PLC
    • ISE Chemicals Corporation
    • Itochu Chemical Frontier Corporation
    • Kanto Natural Gas Development Co. Ltd
    • NIPPOH CHEMICALS CO. LTD
    • Parad Corporation Pvt. Ltd
    • Protochem
    • Salvi Chemical Industries Ltd
    • Samrat Pharmachem Limited
    • SQM SA
    • Toho Earthtech inc.
    • Unilab Chemicals & Pharmaceuticals Pvt. Ltd.

第7章 市場機會及未來趨勢

  • 除生物劑使用需求不斷成長
簡介目錄
Product Code: 69271

The Iodine Market size is estimated at 40.64 kilotons in 2024, and is expected to reach 52.88 kilotons by 2029, growing at a CAGR of 5.41% during the forecast period (2024-2029).

Iodine - Market

The COVID-19 outbreak, nationwide lockdowns worldwide, disruption in manufacturing activities and supply chains, and production halts negatively impacted the market. However, the demand from the medical industry and recovery conditions in 2021 restored the market's growth trajectory during the forecast period.

Key Highlights

  • Over the short term, the increasing demand for X-ray contrast media, growing iodine deficiency among people, and vast applications of iodine derivatives are expected to drive the demand for iodine.
  • However, the toxicity of iodine and health-related issues due to excessive consumption pose major restraints in the market studied.
  • Nevertheless, the rising demand for biocides is expected to act as an opportunity.
  • By application, the medical sector is expected to dominate the market, owing to the increase in the usage of iodine to cure diseases like goiter.
  • Europe dominates the global iodine market, with major consumption in countries such as Germany, the United Kingdom, and France.

Iodine Market Trends

Medical Segment to Dominate the Market

  • Iodine is a chemical element that is the heaviest among all stable halogens. It is a lustrous, purple-black, non-metallic solid at standard conditions, sublimating easily with gentle heat.
  • In the medical sector, the application of iodine includes X-ray contrast media, pharmaceuticals, iodophors, and povidone-iodine (disinfectants). Demand for iodine has increased over the past few years due to the rising need for X-ray contrast media, its low toxicity, high atomic number, and ease of adjunction with organic compounds.
  • Further, iodophors are solutions that contain iodine and a solubilizing agent. This way, a small amount of iodine is slowly released into the solution. One of the most widely used iodophors is povidone-iodine, often used to disinfect surfaces in breweries and dairy industries.
  • The development of medical technologies has propelled the demand for iodine in this application. The radiographic contrast media containing iodine enhances the visibility of vascular structures and organs during radiographic procedures.
  • Radioactive iodine is an effective type of treatment for cancer of the thyroid gland. This is because the radioactive iodine from the drink or capsule is absorbed into the body and picked up by the thyroid cancer cells, even if they have spread to other parts of the body. The radiation then destroys the cancer cells.
  • The European Federation of Pharmaceutical Industries and Associations' (EFPIA) oncology platform provides an environment to support medical innovation in Europe and help deliver new treatments to benefit of people living with cancer. Under this, research continues at pace with over 1,400 cancer medicines in development and over 1,300 oncology clinical trials started in 2021.
  • Moreover, iodine is used in pharmaceuticals to prepare disinfectants, bactericides, and analgesics, among others (for example, tincture of iodine), which is used in synthesizing sodium iodide, potassium iodide, and iodine solution.
  • Furthermore, the pharmaceutical industry stands to be the largest in North America, followed by Europe and Asia-Pacific. Currently, in Asia-Pacific countries, such as India, China, and Indonesia, the pharmaceutical industry's growth is fast-paced and quickly evolving, with generic drug production dominating regional pharmaceutical production.
  • According to the IBEF, India's domestic pharmaceutical market is USD 42 billion in 2021 and is expected to reach USD 120-130 billion by 2030.
  • With such initiatives, research and development, and heavy demand from the medical sector, the demand for iodine is expected to increase in the forecast period.

Europe to Dominate the Market

  • Europe is the major market for iodine consumption, owing to increasing consumption from countries such as Germany, the United Kingdom, and France, among others.
  • Germany is one of the world's largest and most powerful economies. The development of medical technologies and the huge demand for animal feed have propelled the demand for iodine in the country.
  • According to Altech Agri-Food Outlook 2022, the country produced around 24.51 million metric tons of feed in 2021, compared to 24.93 million metric tons in 2020.
  • The country is home to about five of the world's largest animal feed manufacturers, including AGRAVIS Raiffeisen AG, DTC Deutsche Tiernahrung Cremer GmbH & Co. KG, H. Broring GmbH & Co. KG, MEGA Tierernahrung GMBH & Co. KG, and Rothkotter-Mischfutterwerk.
  • However, in 2021, compounded feed production has been severely affected due to the spread of the animal disease Avian Influenza (AI). Overall, the country was likely to experience flattened growth in the feed industry, with expectations of growth in 2022. Hence, such trends have also impacted the demand for iodine in the country during the year.
  • The increasing geriatric population and the increasing requirement for medical facilities for the treatment of chronic diseases are expected to support the growth of the pharmaceutical sector and the consumption of iodine for the production of medicines in the country over the forecast period.
  • Further, the pharmaceutical industry in the United Kingdom is accelerating with investments in research and development or innovations and in the addition of manufacturing sites in the country.
  • The United Kingdom's pharmaceutical market is among the global top 10 national markets, holding some 2.5% of the global pharmaceutical sector. Of all the pharmaceutical products produced in the United Kingdom, 41% are exported, 30% are for the domestic market, and the remaining (28%) are substances that are used in the production of other pharmaceutical products.
  • According to Office for National Statistics (United Kingdom), the manufacturing of basic pharmaceutical products increased by 3.2% in May 2022, compared to the previous month. Moreover, in Q4 2021, the manufacturing of basic pharmaceutical products and pharmaceutical preparations has increased by 12.5% compared to Q3 2021.
  • As on June 1, 2021, the United Kingdom continued to observe a decline in the population of sheep and lambs by 2.7% to 14.63 million compared to the same period last year. However, the population of pigs (4.24 million) and poultry (141.08 million) recorded growth of 5.4% and 5%, respectively. Hence, the consumption of animal feed is also expected to increase in the country with growth in feedstock.
  • The French domestic pharmaceutical market is highly regulated, particularly for reimbursable drugs, which account for approximately 30% of sales. Generic drug manufacturers compete fiercely with brand-name drug manufacturers.

Iodine Industry Overview

The market studied is consolidated, with the top four players accounting for about ~70% of the global market. Major companies (not in any particular order) in the market include SQM SA, ISE CHEMICALS CORPORATION, Cosayach, Iochem Corporation, and Algorta Norte.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing Demand in X-ray Contrast Media
    • 4.1.2 Growing Iodine Deficiency among People
    • 4.1.3 Vast Applications of Iodine Derivatives
  • 4.2 Restraints
    • 4.2.1 Toxicity of Iodine and Health-related Issues
    • 4.2.2 Other Restraints
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION (Market Size in Volume)

  • 5.1 Source
    • 5.1.1 Underground Brine
    • 5.1.2 Caliche Ore
    • 5.1.3 Recycling
    • 5.1.4 Seaweeds
  • 5.2 Form
    • 5.2.1 Inorganic Salts and Complexes
    • 5.2.2 Organic Compounds
    • 5.2.3 Elementals and Isotopes
  • 5.3 Application
    • 5.3.1 Animal Feeds
    • 5.3.2 Medical
    • 5.3.3 Biocides
    • 5.3.4 Optical Polarizing Films
    • 5.3.5 Fluorochemicals
    • 5.3.6 Nylon
    • 5.3.7 Other Applications (Human Nutrition and Catalysts)
  • 5.4 Geography
    • 5.4.1 Asia-Pacific
      • 5.4.1.1 China
      • 5.4.1.2 India
      • 5.4.1.3 Japan
      • 5.4.1.4 South Korea
      • 5.4.1.5 Rest of Asia-Pacific
    • 5.4.2 North America
      • 5.4.2.1 United States
      • 5.4.2.2 Canada
      • 5.4.2.3 Mexico
    • 5.4.3 Europe
      • 5.4.3.1 Germany
      • 5.4.3.2 France
      • 5.4.3.3 United Kingdom
      • 5.4.3.4 Italy
      • 5.4.3.5 Rest of Europe
    • 5.4.4 South America
      • 5.4.4.1 Brazil
      • 5.4.4.2 Argentina
      • 5.4.4.3 Rest of South America
    • 5.4.5 Middle-East and Africa
      • 5.4.5.1 Saudi Arabia
      • 5.4.5.2 South Africa
      • 5.4.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 ACF Minera SA
    • 6.4.2 American Elements
    • 6.4.3 Algorta Norte SA
    • 6.4.4 Calibre Chemicals Pvt. Ltd
    • 6.4.5 Cosayach
    • 6.4.6 Deep Water Chemicals
    • 6.4.7 Eskay Iodine
    • 6.4.8 Glide Chem Private Limited
    • 6.4.9 GODO SHIGEN Co. Ltd
    • 6.4.10 Infinium Pharmachem Pvt. Ltd
    • 6.4.11 Iochem Corporation
    • 6.4.12 Iofina PLC
    • 6.4.13 ISE Chemicals Corporation
    • 6.4.14 Itochu Chemical Frontier Corporation
    • 6.4.15 Kanto Natural Gas Development Co. Ltd
    • 6.4.16 NIPPOH CHEMICALS CO. LTD
    • 6.4.17 Parad Corporation Pvt. Ltd
    • 6.4.18 Protochem
    • 6.4.19 Salvi Chemical Industries Ltd
    • 6.4.20 Samrat Pharmachem Limited
    • 6.4.21 SQM SA
    • 6.4.22 Toho Earthtech inc.
    • 6.4.23 Unilab Chemicals & Pharmaceuticals Pvt. Ltd.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Rising Demand in Usage of Biocides